MARIS Buy Hold or Sell Recommendation

<div class='circular--portrait' style='background:#4E8BFC;color: #ffffff;font-size:4em;padding-top: 25px;;'>MS</div>
MARIS -- India Stock  

INR 6.39  0.00  0.00%

Assuming 30 trading days horizon, and your above average risk tolerance our recommendation regarding MARIS SPINNERS LTD is 'Strong Sell'. Macroaxis provides MARIS SPINNERS buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding MARIS positions. The advice algorithm takes into account all of MARIS SPINNERS LTD available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from MARIS buy-and-hold perspective. Additionally, see MARIS SPINNERS Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments please use Instant Ratings tool.

Search Advice


Time Horizon

Risk Tolerance

Execute Advice
Strong Sell


Hype Condition

Current Valuation

Odds of Distress

Analyst Consensus

Not Available
For the selected time horizon MARIS SPINNERS LTD has a mean deviation of 2.83, semi deviation of 0.0, standard deviation of 4.33, variance of 18.71, downside variance of 0.0 and semi variance of 0.0
We provide buy, hold, or sell recommendation to complement the last-minute expert consensus on MARIS SPINNERS LTD. Our dynamic recommendation engine harnesses multi - dimensional algorithm to analyze the company potential to grow using all technical and fundamental data available today. To make sure MARIS SPINNERS LTD is not overpriced, please verify all MARIS SPINNERS LTD fundamentals, including its Current Ratio, and the relationship between Net Income and Market Capitalization .

MARIS SPINNERS Trading Alerts and Improvement Suggestions

MARIS SPINNERS LTD generates negative expected return over the last 30 days
MARIS SPINNERS LTD has high historical volatility and very poor performance
The company reported revenue of 1.31 B. Net Loss for the year was (27.1 M) with profit before overhead, payroll, taxes, and interest of 476.47 M.

MARIS SPINNERS Returns Distribution Density

Mean Return-1.43Value At Risk-9.41
Potential Upside4.93Standard Deviation4.33
 Return Density 


Alpha over DOW
Beta against DOW=-0.14
Overall volatility
Information ratio =-0.35

MARIS SPINNERS Volatility Alert

MARIS SPINNERS LTD exhibits very low volatility with skewness of -1.91 and kurtosis of 8.13. However, we advise investors to further study MARIS SPINNERS LTD technical indicators to make sure all market info is available and is reliable.
 Better Than Average     
 Worse Than Average Compare MARIS SPINNERS to competition

MARIS SPINNERS Fundamental Vs Peers

FundamentalsMARIS SPINNERSPeer Average
Return On Equity(7.91) (0.31) 
Return On Asset1.83 (0.14) 
Profit Margin(2.08) (1.27) 
Operating Margin0.85 (5.51) 
Current Valuation410.99 M16.62 B
Shares Outstanding8.17 M571.82 M
Price to Earning18.40 28.72 
Price to Book0.23 9.51 
Price to Sales0.04 11.42 
Revenue1.31 B9.43 B
Gross Profit476.47 M27.38 B
EBITDA54.98 M3.9 B
Net Income(27.1 M)570.98 M
Cash and Equivalents5.78 M2.7 B
Cash per Share0.71 5.01 
Total Debt364.86 M5.32 B
Debt to Equity1.62 48.70 
Current Ratio1.06 2.16 
Book Value Per Share27.57 1.93 K
Earnings Per Share(3.32) 3.12 
Number of Employees19318.84 K
Market Capitalization51.89 M19.03 B
Total Asset834 M29.47 B
Working Capital(30 M)1.48 B
Current Asset467 M9.34 B
Current Liabilities497 M7.9 B
Z Score1.08.72
Last Dividend Paid1.0

About MARIS SPINNERS Buy or Sell Advice

When is the right time to buy or sell MARIS SPINNERS LTD? Buying stocks such as MARIS SPINNERS isn't very hard. However, what challenging for most investors is doing it at the right time to beat the stock market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily bases. Although MARIS SPINNERS investors may find it confusing at the beginning, most of our advising modules are very easy to use and apply. Please read more on our stock advisor page.

Did You Try This Idea?

Run Drugs Thematic Idea Now

Drugs Theme
Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. Drugs theme has 30 constituents.
View All  Next Launch Drugs
Additionally, see MARIS SPINNERS Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments please use Instant Ratings tool. Please also try CEO Directory module to screen ceos from public companies around the world.
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page